OKLAHOMA CITY (May 1, 2023) – Attorney General Gentner Drummond is leading a coalition of 26 attorneys general in urging the Centers for Medicare and Medicaid Services (CMS) to provide coverage for a drug approved by the U.S. Food and Drug Administration (FDA) that has been proven to delay the progression of Alzheimer’s Disease.
In an April 26 letter, Drummond asked CMS to provide full and unrestricted Medicare coverage for FDA-approved Alzheimer’s treatments, consistent with its decades-long practice of covering FDA-approved prescription drugs for Medicare beneficiaries.